Home Capital Results

QT Vascular’s 3Q losses narrow to US$9.5 mil on higher sales

Benjamin Cher
Benjamin Cher11/14/2016 06:37 PM GMT+08  • 2 min read
QT Vascular’s 3Q losses narrow to US$9.5 mil on higher sales
SINGAPORE (Nov 14): QT Vascular, the manufactuer of drug-coated balloon catheters, reported 3Q losses narrowed 71.2% to US$9.5 million ($13.4 million) from a year ago on lower expenses.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Nov 14): QT Vascular, the manufactuer of drug-coated balloon catheters, reported 3Q losses narrowed 71.2% to US$9.5 million ($13.4 million) from a year ago on lower expenses.

Revenue for the quarter dipped 5.4% to US$2.3 million, dragged down by lower sales of the Chocolate PTA Balloon Catheter, although this was partially offset by the increase in sales of the Chocolate PTCA Balloon Catheter and Glider PTCA by the direct sales team. The direct sales team has seen a 64.5% increase in average sales per sales representative to US$92,332 in 3Q16.

However, results from operating activities fell 80.1% to US$.7 million as administrative expenses fell 56.4% to US$1.7 million and the absence of other expenses of US$21.3 million which was recorded a year ago.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now